|
EVI5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.606480E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.639100E-04 |
| Normal-vs-Stage2 |
3.791800E-02 |
| Normal-vs-Stage3 |
4.032300E-04 |
| Normal-vs-Stage4 |
2.8055000000915E-07 |
| Stage1-vs-Stage2 |
7.065600E-01 |
| Stage1-vs-Stage3 |
4.298800E-01 |
| Stage1-vs-Stage4 |
5.224500E-03 |
| Stage2-vs-Stage3 |
4.072600E-01 |
| Stage2-vs-Stage4 |
4.162000E-02 |
| Stage3-vs-Stage4 |
7.975900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.976900E-04 |
| Normal-vs-AfricanAmerican |
6.763500E-03 |
| Normal-vs-Asian |
9.177100E-03 |
| Caucasian-vs-AfricanAmerican |
9.091600E-01 |
| Caucasian-vs-Asian |
7.650400E-01 |
| AfricanAmerican-vs-Asian |
7.530400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.135400E-03 |
| Normal-vs-Female |
1.177590E-04 |
| Male-vs-Female |
6.370800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.617000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.585360E-04 |
| Normal-vs-Age(61-80Yrs) |
1.79254000000073E-05 |
| Normal-vs-Age(81-100Yrs) |
5.349600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.958000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.334500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.298000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.246400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.345800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.225600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.618600E-03 |
| Classical-VS-Follicular |
8.934000E-02 |
| Classical-VS-Other |
1.346430E-01 |
| Classical-VS-Normal |
4.741000E-03 |
| Tall-VS-Follicular |
2.271200E-01 |
| Tall-VS-Other |
6.188600E-01 |
| Tall-VS-Normal |
2.395299999991E-05 |
| Follicular-VS-Other |
3.337200E-01 |
| Follicular-VS-Normal |
1.645760E-04 |
| Other-VS-Normal |
5.296500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.184000E-04 |
| Normal-vs-N1 |
4.16480000000607E-05 |
| N0-vs-N1 |
2.181200E-01 |
|
|
